Literature DB >> 32201900

Correlation Between Expression of CD134, a Human Herpesvirus 6 Cellular Receptor, on CD4+ T cells and Th2-type Immune Responses in Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.

Fumi Miyagawa1, Yuki Nakamura-Nishimura, Yushi Kanatani, Hideo Asada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32201900      PMCID： PMC9128879          DOI： 10.2340/00015555-3465

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  10 in total

1.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

2.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

Authors:  T Shiohara; M Iijima; Z Ikezawa; K Hashimoto
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

3.  Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS).

Authors:  K Ogawa; H Morito; A Hasegawa; F Miyagawa; N Kobayashi; H Watanabe; H Sueki; M Tohyama; K Hashimoto; Y Kano; T Shiohara; K Ito; H Fujita; M Aihara; H Asada
Journal:  Br J Dermatol       Date:  2014-08-02       Impact factor: 9.302

4.  Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).

Authors:  Fumi Miyagawa; Yuki Nakamura; Kazuya Miyashita; Hiroshi Iioka; Yukiko Himuro; Kohei Ogawa; Chizu Nishimura; Mitsuko Nishikawa; Yasuhiro Mitsui; Yumiko Ito; Rie Ommori; Yasuko Mori; Hideo Asada
Journal:  J Dermatol Sci       Date:  2016-05-09       Impact factor: 4.563

5.  Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome.

Authors:  Y Nakamura-Nishimura; F Miyagawa; K Miyashita; R Ommori; H Azukizawa; H Asada
Journal:  Br J Dermatol       Date:  2018-03-25       Impact factor: 9.302

6.  Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).

Authors:  Kohei Ogawa; Hironori Morito; Ayako Hasegawa; Natsuko Daikoku; Fumi Miyagawa; Aiko Okazaki; Takaya Fukumoto; Nobuhiko Kobayashi; Takahiko Kasai; Hideaki Watanabe; Hirohiko Sueki; Masafumi Iijima; Mikiko Tohyama; Koji Hashimoto; Hideo Asada
Journal:  J Dermatol Sci       Date:  2012-10-26       Impact factor: 4.563

7.  Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.

Authors:  Fumi Miyagawa; Ayako Hasegawa; Kyoko Imoto; Kohei Ogawa; Nobuhiko Kobayashi; Kayoko Ito; Hiroyuki Fujita; Michiko Aihara; Hideaki Watanabe; Hirohiko Sueki; Mikiko Tohyama; Hideo Asada
Journal:  Eur J Dermatol       Date:  2015 Jan-Feb       Impact factor: 3.328

8.  Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome.

Authors:  G Choquet-Kastylevsky; L Intrator; C Chenal; H Bocquet; J Revuz; J C Roujeau
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

9.  CD134 is a cellular receptor specific for human herpesvirus-6B entry.

Authors:  Huamin Tang; Satoshi Serada; Akiko Kawabata; Megumi Ota; Emi Hayashi; Tetsuji Naka; Koichi Yamanishi; Yasuko Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

10.  OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors.

Authors:  Y Ohshima; L P Yang; T Uchiyama; Y Tanaka; P Baum; M Sergerie; P Hermann; G Delespesse
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113
  10 in total
  2 in total

Review 1.  Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).

Authors:  Fumi Miyagawa; Hideo Asada
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 2.  The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.

Authors:  Yun-Shiuan Olivia Hsu; Kun-Lin Lu; Yun Fu; Chuang-Wei Wang; Chun-Wei Lu; Yu-Fen Lin; Wen-Cheng Chang; Kun-Yun Yeh; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.